Senior insider sale
VP of Regulatory Affairs at IMMUNOGEN, INC. — senior position signals high conviction
$22.94M
1.06M shares
WINGROVE THERESA plans to sell 1.06M shares of IMMUNOGEN, INC. valued at approximately $22.94M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/3/2024 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 12.03K | — |
| Total | 12.03K | ||
Completed
Units to sell
187.67K
Market value
$5.56M
Units to sell
117.44K
Market value
$3.45M
Units to sell
164.42K
Market value
$4.76M
Units to sell
6.79K
Market value
$113.2K
Units to sell
166.72K
Market value
$2.64M
Units to sell
19.52K
Market value
$325.1K
Units to sell
192K
Market value
$2.76M
Units to sell
192.01K
Market value
$2.97M
Planned — Approximate Date
Units to sell
12.03K
Market value
$352.4K
Units
1.06M
Value
$22.94M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/16/2024 | 187.67K | $5.56M | — | Completed |
12/15/2023 | 117.44K | $3.45M | — | Completed |
11/30/2023 | 164.42K | $4.76M | — | Completed |
11/29/2023 | 6.79K | $113.2K | — | Completed |
11/15/2023 | 166.72K | $2.64M | — | Completed |
11/7/2023 | 19.52K | $325.1K | — | Completed |
10/16/2023 | 192K | $2.76M | — | Completed |
9/15/2023 | 192.01K | $2.97M | — | Completed |
| Planned — Approximate Date | ||||
2/5/2024 | 12.03K | $352.4K | NASDAQ | Planned |
| Total | 1.06M | $22.94M | ||